Missi ng links in preeclampsia cell model systems of endothelial dysfunction

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
CELL PRESS
Citação
TRENDS IN MOLECULAR MEDICINE, v.29, n.7, p.541-553, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Preeclampsia, one of the main hypertensive disorders of pregnancy, is associated with circulating factors released by the ischemic placenta accompanied by systemic endothelial dysfunction. The etiology of preeclampsia remains poorly understood although it is associated with high maternal and fetal mortality and increased cardiovascular disease risk. Most cell model systems used for studying endothelial dysfunction have not taken into account hemodynamic physical factors such as shear-stress forces which may prevent extrapolation of cell data to in vivo settings. We overview the role of hemodynamic forces in modulating endothelial cell function and discuss strategies to reproduce this biological characteristic in vitro to improve our understanding of endothelial dysfunction associated with preeclampsia.
Palavras-chave
Referências
  1. AbdelHalim RM, 2016, MOL DIAGN THER, V20, P135, DOI 10.1007/s40291-015-0184-x
  2. Adank MC, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.03.025
  3. Bai J, 2021, BIOMATERIALS, V268, DOI 10.1016/j.biomaterials.2020.120592
  4. Bai KH, 2013, ACTA BIOCH BIOPH SIN, V45, P749, DOI 10.1093/abbs/gmt059
  5. Baker PN, 1996, AM J OBSTET GYNECOL, V174, P730, DOI 10.1016/S0002-9378(96)70457-X
  6. Benny PA, 2020, PLACENTA, V92, P17, DOI 10.1016/j.placenta.2020.01.008
  7. Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009
  8. Burton G.J., 2019, BMJ, V366, pI2381
  9. Cakmak M, 2016, CLIN EXP HYPERTENS, V38, P137, DOI 10.3109/10641963.2015.1060993
  10. Calicchio R, 2013, AM J PATHOL, V183, P1993, DOI 10.1016/j.ajpath.2013.08.020
  11. Carter AM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22158099
  12. Kim JJ, 2010, CELL DEATH DIFFER, V17, P1420, DOI 10.1038/cdd.2010.19
  13. Kim JY, 2015, J PATHOL TRANSL MED, V49, P462, DOI 10.4132/jptm.2015.10.23
  14. Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x
  15. Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534
  16. Kublickiene KR, 2000, AM J OBSTET GYNECOL, V183, P160, DOI 10.1067/mob.2000.105820
  17. Kulkarni AV, 2010, HYPERTENS RES, V33, P561, DOI 10.1038/hr.2010.31
  18. Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0
  19. Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603
  20. Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036
  21. Lee ES, 2007, J KOREAN MED SCI, V22, P94, DOI 10.3346/jkms.2007.22.1.94
  22. Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189
  23. Lee SM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.047
  24. Levi M, 2005, TRENDS CARDIOVAS MED, V15, P254, DOI 10.1016/j.tcm.2005.07.004
  25. Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884
  26. Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701
  27. Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1
  28. Luizon MR, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.678184
  29. Luscher TF, 1997, CLIN CARDIOL, V20, P3
  30. Magee LA, 2022, PREGNANCY HYPERTENS, V27, P148, DOI 10.1016/j.preghy.2021.09.008
  31. Mahmoud MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03532-z
  32. Masoura S, 2014, EUR J OBSTET GYN R B, V175, P119, DOI 10.1016/j.ejogrb.2014.01.012
  33. McElwain CJ, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00655
  34. Mitra AK, 2010, AM J PHYSIOL-CELL PH, V299, pC561, DOI 10.1152/ajpcell.00127.2010
  35. Moufarrej MN, 2022, NATURE, V602, P689, DOI 10.1038/s41586-022-04410-z
  36. Muijsers HEC, 2019, CURR CARDIOVASC RISK, V13, DOI 10.1007/s12170-019-0614-0
  37. Munoz-Hernandez R, 2017, AM J HYPERTENS, V30, P673, DOI 10.1093/ajh/hpx024
  38. Mutter WP, 2008, MICROVASC RES, V75, P1, DOI 10.1016/j.mvr.2007.04.009
  39. Myers J, 2005, HYPERTENSION, V45, P258, DOI 10.1161/01.HYP.0000153461.58298.a4
  40. Nabweyambo S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251227
  41. Palei AC, 2013, ACTA PHYSIOL, V208, P224, DOI 10.1111/apha.12106
  42. Rana S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048259
  43. Pan LF, 2017, MOL MED REP, V16, P7205, DOI 10.3892/mmr.2017.7524
  44. Pandey AK, 2018, HYPERTENSION, V71, pE1, DOI 10.1161/HYPERTENSIONAHA.117.10271
  45. Perucci LO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097632
  46. Pinheiro-de-Sousa I, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-05404-7
  47. Platt MO, 2007, AM J PHYSIOL-HEART C, V292, pH1479, DOI 10.1152/ajpheart.00954.2006
  48. Platt MO, 2006, ARTERIOSCL THROM VAS, V26, P1784, DOI 10.1161/01.ATV.0000227470.72109.2b
  49. Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127
  50. Rafaeli-Yehudai T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200360
  51. Rana S, 2022, AM J OBSTET GYNECOL, V226, pS1019, DOI 10.1016/j.ajog.2020.10.022
  52. Rana S, 2019, CIRC RES, V124, P1094, DOI 10.1161/CIRCRESAHA.118.313276
  53. REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H
  54. Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009
  55. Roberts JM, 2021, HYPERTENSION, V77, P1430, DOI 10.1161/HYPERTENSIONAHA.120.14781
  56. Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
  57. ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0
  58. Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480
  59. Rowe J, 2003, HYPERTENS PREGNANCY, V22, P63, DOI 10.1081/PRG-120017005
  60. Rusterholz C, 2011, HYPERTENS PREGNANCY, V30, P364, DOI 10.3109/10641951003599571
  61. Sahay AS, 2014, HYPERTENS RES, V37, P753, DOI 10.1038/hr.2014.71
  62. Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111
  63. Sandrim Valeria Cristina, 2016, J Cell Mol Med, V20, P1198, DOI 10.1111/jcmm.12767
  64. Sani HM, 2019, BIOMED PHARMACOTHER, V109, P408, DOI 10.1016/j.biopha.2018.10.082
  65. Scharfe-Nugent A, 2012, J IMMUNOL, V188, P5706, DOI 10.4049/jimmunol.1103454
  66. Siljee JE, 2013, PRENATAL DIAG, V33, P1183, DOI 10.1002/pd.4219
  67. Souilhol C, 2018, CARDIOVASC RES, V114, P565, DOI 10.1093/cvr/cvx253
  68. Southcombe J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020245
  69. Staff AC, 2019, J REPROD IMMUNOL, V134, P1, DOI 10.1016/j.jri.2019.07.004
  70. Staff AC, 2014, J REPROD IMMUNOL, V101, P120, DOI 10.1016/j.jri.2013.09.001
  71. Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59
  72. Taylor EB, 2022, ENDOCRINOLOGY, V163, DOI 10.1210/endocr/bqac096
  73. Tomimatsu T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174246
  74. Urschel K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115635
  75. Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557
  76. van Thienen JV, 2006, CARDIOVASC RES, V72, P231, DOI 10.1016/j.cardiores.2006.07.008
  77. van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476
  78. Veerbeek JHW, 2015, HYPERTENSION, V65, P600, DOI 10.1161/HYPERTENSIONAHA.114.04850
  79. Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429
  80. Wang L, 2016, NATURE, V540, P579, DOI 10.1038/nature20602
  81. Wang W, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03809-2
  82. Celik H, 2013, J OBSTET GYNAECOL, V33, P355, DOI 10.3109/01443615.2013.769944
  83. Weissgerber TL, 2016, HYPERTENSION, V67, P415, DOI 10.1161/HYPERTENSIONAHA.115.06554
  84. Williams MA, 1999, AM J EPIDEMIOL, V149, P323
  85. Wu L, 2012, REPRODUCTION, V143, P389, DOI 10.1530/REP-11-0304
  86. Xu SW, 2021, PHARMACOL REV, V73, P924, DOI 10.1124/pharmrev.120.000096
  87. Yamashiro Y, 2020, CLIN SCI, V134, P2399, DOI 10.1042/CS20190488
  88. Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942
  89. Yang Q, 2011, CLIN CHIM ACTA, V412, P2167, DOI 10.1016/j.cca.2011.07.029
  90. Yuan XS, 2019, CLIN BIOCHEM, V71, P46, DOI 10.1016/j.clinbiochem.2019.07.001
  91. Yun S, 2016, NAT CELL BIOL, V18, P1043, DOI 10.1038/ncb3405
  92. Zhong XY, 2002, HYPERTENS PREGNANCY, V21, P77, DOI 10.1081/PRG-120002911
  93. Chen Y, 2012, INT J GYNECOL OBSTET, V119, P234, DOI 10.1016/j.ijgo.2012.07.010
  94. Chistiakov DA, 2017, ACTA PHYSIOL, V219, P382, DOI 10.1111/apha.12725
  95. Cirkovic A, 2021, FRONT BIOENG BIOTECH, V9, DOI 10.3389/fbioe.2021.782845
  96. Conrad KP, 1998, AM J REPROD IMMUNOL, V40, P102
  97. Daiber A, 2020, FREE RADICAL BIO MED, V157, P15, DOI 10.1016/j.freeradbiomed.2020.02.026
  98. Demos C., 2021, BIOMECHANICS CORONAR, P3
  99. Dimitriadis E, 2023, NAT REV DIS PRIMERS, V9, DOI 10.1038/s41572-023-00417-6
  100. Diniz ALD, 2020, CURR ATHEROSCLER REP, V22, DOI 10.1007/s11883-020-0830-6
  101. Elawad T, 2022, BJOG-INT J OBSTET GY, DOI 10.1111/1471-0528.17320
  102. FALCONE JC, 1993, AM J PHYSIOL, V264, pH653, DOI 10.1152/ajpheart.1993.264.2.H653
  103. Gallo G., 2022, FRONT MED-LAUSANNE, V8, P3022
  104. Gallos ID, 2013, BJOG-INT J OBSTET GY, V120, P1321, DOI 10.1111/1471-0528.12375
  105. Gerson KD, 2019, PREGNANCY HYPERTENS, V16, P148, DOI 10.1016/j.preghy.2019.04.002
  106. GIMBRONE MA, 1995, AM J CARDIOL, V75, pB67, DOI 10.1016/0002-9149(95)80016-L
  107. Gordon E, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00684
  108. Goulopoulou S, 2015, TRENDS MOL MED, V21, P88, DOI 10.1016/j.molmed.2014.11.009
  109. Guller S, 2011, PLACENTA, V32, P63, DOI 10.1016/j.placenta.2010.10.011
  110. Gupta AK, 2005, PLACENTA, V26, P59, DOI 10.1016/j.placenta.2004.04.004
  111. Haase K, 2020, ADV FUNCT MATER, V30, DOI 10.1002/adfm.202002444
  112. Hamai Y, 1997, AM J REPROD IMMUNOL, V38, P89
  113. Hasan SS, 2021, TRENDS CELL BIOL, V31, P37, DOI 10.1016/j.tcb.2020.10.003
  114. Hsieh CY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-12
  115. Hunter A, 2000, HYPERTENSION, V36, P965, DOI 10.1161/01.HYP.36.6.965
  116. Jiang YZ, 2014, CIRC RES, V115, P32, DOI 10.1161/CIRCRESAHA.115.303883
  117. Jones CI, 2007, ANN BIOMED ENG, V35, P683, DOI 10.1007/s10439-007-9279-9
  118. Jonsson Y, 2006, J REPROD IMMUNOL, V70, P83, DOI 10.1016/j.jri.2005.10.007
  119. Karczewski KJ, 2018, NAT REV GENET, V19, P299, DOI 10.1038/nrg.2018.4
  120. Kenneth NS, 2009, J BIOL CHEM, V284, P4123, DOI 10.1074/jbc.M808491200